Fractional CO2 Laser Therapy Versus 4% Topical Lidocaine Gel for Dyspareunia in Breast Cancer Survivors
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Dyspareunia
Interventions: DRUG: 4% Topical Lidocaine Gel|DEVICE: CO2RE fractional laser therapy
Sponsor: University of Cincinnati
Collaborators: Syneron Candela